incretin and glp-1 Targeting both incretin receptors together

00:10:07 Vickie Danaher And we can explain to our patients like Angela in our case that overall the side effects of orforglipron are pretty similar to what we see with the other GLP-1 receptor agonists

This article summarises the position reached with the GLP-1 RAs and reviews the developing field of unimolecular co-agonists that act not only on the GLP-1 receptor, but on other receptors, notably glucose-dependent insulotropic polypeptide (GIP) and glucagon receptors, with the aim of further improving glycaemic control and weight reduction

Over time, the body typically adapts, but the underlying mechanics of digestion remain permanently altered

This includes enlarged hands, feet, jaw, and internal organ enlargement (for example: heart, liver)

Separation was conducted at a constant temperature of 30 C using a mobile phase of 5% (v/v) acetonitrile, 0.05% (v/v) trifluoroacetic acid, and 0.1 M sodium perchlorate at a flow rate of 0.5 mL/min

Mechanism of Action GLP-1 agonists bind to GLP-1 receptors, enhancing insulin secretion and decreasing glucagon production, which aids in controlling blood sugar levels